Physician profile
Luiz E Malini
NPI 1861603532
$3,951.92
in general payments reported to CMS, 2019-2025
41 companies · $553 in 2025
The $553 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,213 · 2020: $576 · 2021: $38.76 · 2022: $103 · 2023: $519 · 2024: $950 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,021.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $651.66 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $432.74 | 2019-2025 | |
| Lilly USA, LLC | $343.31 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $253.09 | 2019-2025 | Otezla, Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $242.77 | 2022-2025 | |
| Exact Sciences Corporation | $173.15 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $160.37 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $152.14 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.82 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $121.64 | 2019-2025 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $115.34 | 2019-2024 | Breztri |
| E.R. Squibb & Sons, L.L.C. | $97.27 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $97.09 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $96.84 | 2019-2020 | |
| Allergan, INC. | $83.60 | 2019-2020 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luiz Malini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.